Verdict Medical Devices

AccuStem to launch MSC blood test for lung cancer screening in US

AccuStem Sciences is set to launch the microRNA Signature Classifier (MSC) blood test for the US lung cancer screening programmes. The post AccuStem to launch MSC blood test for lung cancer screening in US appeared first on Medical Device Network.

Apr 7, 2025 - 11:22
 0
AccuStem to launch MSC blood test for lung cancer screening in US
AccuStem Sciences is set to launch the microRNA Signature Classifier (MSC) blood test for the US lung cancer screening programmes.

The post AccuStem to launch MSC blood test for lung cancer screening in US appeared first on Medical Device Network.

Read More

Tags:

Previous Article

“Pasta sauce has taken off as a rocket ship for our brand” – Botticelli Foods VP...

Next Article

Fein breaks ground on 326-unit City Place apartment complex

Related Posts

OCT West Coast 2025: Recruitment and regulation still pain points

OCT West Coast 2025: Recruitment and regulation still p...

Feb 20, 2025  0

Wearable defib maker Kestra targets $154m IPO

Wearable defib maker Kestra targets $154m IPO

Feb 27, 2025  0

Thermo Fisher introduces Evos S1000 imaging system for spatial tissue proteomics

Thermo Fisher introduces Evos S1000 imaging system for ...

Feb 13, 2025  0